Neuropathy

Canadian Journal of Diabetes

Volumn 37, Issue SUPPL.1, 2013, Pages

  Bril, Vera ^a   Perkins, Bruce ^a   Toth, Cory ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CAPSAICIN; DEXTROMETHORPHAN; DULOXETINE; GABAPENTIN; MORPHINE; NITRIC ACID DERIVATIVE; OPIATE; OXYCODONE; PREGABALIN; TAPENTADOL; TRAMADOL; VALPROIC ACID; VENLAFAXINE;

ARTICLE; AUTONOMIC NEUROPATHY; BEDTIME DOSAGE; CANADA; CLINICAL PRACTICE; DIABETIC NEUROPATHY; DRUG COST; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MEDICAL SOCIETY; NERVE SURGERY; PRACTICE GUIDELINE; PRIMARY PREVENTION; RECOMMENDED DRUG DOSE; TRANSCUTANEOUS NERVE STIMULATION; TRIACYLGLYCEROL BLOOD LEVEL; TUNING FORK; DIABETIC NEUROPATHIES;

CANADA; DIABETIC NEUROPATHIES; HUMANS;

EID: 84876068579     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcjd.2013.01.039     Document Type: Article

References (56)

1. Dyck P.J., Kratz K.M., Karnes J.L., et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993, 43:817-824.
2. Nelson D., Mah J.K., Adams C., et al. Comparison of conventional and non-invasive techniques for the early identification of diabetic neuropathy in children and adolescents with type 1 diabetes. Pediatr Diabetes 2006, 7:305-310.
3. Singleton J.R., Smith A.G., Bromberg M.B. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 2001, 24:1448-1453.
4. Tesfaye S., Chaturvedi N., Eaton S.E., et al. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005, 352:341-350.
5. Young M.J., Breddy J.L., Veves A., et al. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care 1994, 17:557-560.
6. Reiber G.E., Boyko E.J., Smith D.G. Lower extremity foot ulcers and amputations in diabetes. Diabetes in America 1995, 409-428. National Diabetes Data Group, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. 2nd ed.
7. Partanen J., Niskanen L., Lehtinen J., et al. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995, 333:89-94.
8. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986. The Diabetes Control and Complications Trial Research Group.
9. daCosta DiBonaventura M., Cappelleri J.C., Joshi A.V. A longitudinal assessment of painful diabetic peripheral neuropathy on health status, productivity, and health care utilization and cost. Pain Med 2011, 12:118-126.
10. Perkins B.A., Olaleye D., Bril V. Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care 2002, 25:565-569.
11. Herman W.H., Kennedy L. Underdiagnosis of peripheral neuropathy in type 2 diabetes. Diabetes Care 2005, 28:1480-1481.
12. Kanji J.N., Anglin R.E., Hunt D.L., et al. Does this patient with diabetes have large-fiber peripheral neuropathy?. JAMA 2010, 303:1526-1532.
13. Perkins B.A., Olaleye D., Zinman B., et al. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care 2001, 24:250-256.
14. Rith-Najarian S.J., Stolusky T., Gohdes D.M. Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting. A prospective evaluation of simple screening criteria. Diabetes Care 1992, 15:1386-1389.
15. Rahman M., Griffin S.J., Rathmann W., et al. How should peripheral neuropathy be assessed in people with diabetes in primary care? A population-based comparison of four measures. Diabet Med 2003, 20:368-374.
16. Perkins B.A., Orszag A., Olaleye D., et al. Prediction of incident diabetic neuropathy using the monofilament exam: a 4-year prospective study. Diabetes Care 2010, 33:1549-1554.
17. Reichard P., Berglund B., Britz A., et al. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years. J Intern Med 1991, 230:101-108.
18. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 1995, 122:561-568. The Diabetes Control and Complications Trial Research Group.
19. Albers J.W., Herman W.H., Pop-Busui R., et al. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care 2010, 33:1090-1096.
20. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853. UK Prospective Diabetes Study (UKPDS) Group.
21. Bril V., England J., Franklin G.M., et al. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011, 3:345-352. 352.e1-21.
22. McQuay H., Carroll D., Jadad A.R., et al. Anticonvulsant drugs for management of pain: a systematic review. BMJ 1995, 311:1047-1052.
23. Backonja M., Beydoun A., Edwards K.R., et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998, 280:1831-1836.
24. Richter R.W., Portenoy R., Sharma U., et al. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 2005, 6:253-260.
25. Lesser H., Sharma U., LaMoreaux L., et al. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 2004, 63:2104-2110.
26. Rosenstock J., Tuchman M., LaMoreau L., et al. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004, 110:628-638.
27. Kochar D.K., Jain N., Agarwal R.P., et al. Sodium valproate in the management of painful neuropathy in type 2 diabetes: a randomized placebo controlled study. Acta Neurol Scand 2002, 106:248-252.
28. Kochar D.K., Rawat N., Agrawal R.P., et al. Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study. QJM 2004, 97:33-38.
29. Guan Y., Ding X., Cheng Y., et al. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China. Clin Ther 2011, 33:159-166.
30. Satoh J., Yagihashi S., Baba M., et al. Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial. Diabet Med 2011, 28:109-116.
31. Max M.B., Culnane M., Schafer S.C., et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987, 37:589-596.
32. Max M.B., Lynch S.A., Muir J., et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992, 326:1250-1256.
33. Goldstein D.J., Lu Y., Detke M.J., et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005, 116:109-118.
34. Raskin J., Smith T.R., Wong K., et al. Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain. J Palliat Med 2006, 9:29-40.
35. Raskin J., Wang F., Pritchett Y.L., et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005, 6:346-356.
36. Wernicke J.F., Pritchett Y.L., D'Souza D.N., et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 2006, 67:1411-1420.
37. Rowbotham M.C., Goli V., Kunz N.R., et al. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 2004, 110:697-706.
38. Kadiroglu A.K., Sit D., Kayabasi H., et al. The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus. J Diabetes Complicat 2008, 22:241-245.
39. Kaur H., Hota D., Bhansali A., et al. A comparative evaluation of amitriptyline and duloxetine in painful diabetic neuropathy, a randomized, double-blind, cross-over clinical trial. Diabetes Care 2011, 34:818-822.
40. Yasuda H., Hotta N., Nakao K., et al. Superiority of duloxetine to placebo in improving diabetic neuropathic pain: results of a randomized controlled trial in Japan. J Diabetes Investig 2011, 2:132-139.
41. Sang C.N., Booher S., Gilron I., et al. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. Anesthesiology 2002, 96:1053-1061.
42. Nelson K.A., Park K.M., Robinovitz E., et al. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997, 48:1212-1218.
43. Gimbel J.S., Richards P., Portenoy R.K. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology 2003, 60:927-934.
44. Harati Y., Gooch C., Swenson M., et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998, 50:1842-1846.
45. Schwartz S., Etropolski M., Shapiro D.Y., et al. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial. CMRO 2011, 27:151-162.
46. Yuen K.C., Baker N.R., Rayman G. Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double- blind placebo-controlled cross-over study. Diabetes Care 2002, 25:1699-1703.
47. Agrawal R.P., Choudhary R., Sharma P., et al. Glyceryl trinitrate spray in the management of painful diabetic neuropathy: a randomized double blind placebo controlled cross-over study. Diabetes Res Clin Pract 2007, 77:161-167.
48. Low P.A., Opfer-Gehrking T.L., Dyck P.J., et al. Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy. Pain 1995, 62:163-168.
49. Treatment of painful diabetic neuropathy with topical capsaicin.A multicenter, double-blind, vehicle-controlled study. Arch Intern Med 1991, 151:2225-2229. The Capsaicin Study Group.
50. Tandan R., Lewis G.A., Krusinski P.B., et al. Topical capsaicin in painful diabetic neuropathy. Controlled study with long-term follow-up. Diabetes Care 1992, 15:8-14.
51. Agrawal R.P., Goswami J., Jain S., et al. Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: a prospective double-blind randomized placebo-controlled study. Diabetes Res Clin Pract 2009, 83:371-378.
52. Kumar D., Alvaro M.S., Julka I.S., et al. Diabetic peripheral neuropathy. Effectiveness of electrotherapy and amitriptyline for symptomatic relief. Diabetes Care 1998, 21:1322-1325.
53. Bosi E., Conti M., Vermigli C., et al. Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy. Diabetologia 2005, 48:817-823.
54. Chaudhry V., Stevens J.C., Kincaid J., et al. Practice advisory: utility of surgical decompression for treatment of diabetic neuropathy: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2006, 66:1805-1808.
55. Gilron I., Bailey J.M., Tu D., et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005, 352:1324-1334.
56. Hamza M.A., White P.F., Craig W.F., et al. Percutaneous electrical nerve stimulation: a novel analgesic therapy for diabetic neuropathic pain. Diabetes Care 2000, 23:365-370.